Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms

Yuan Yao Zong; Fang Jing Yuan; Zou Duo Wu; Levinson Nigel; Jenner Bartosz; Wilkinson Joanne

首页> 外文期刊>Journal of digestive diseases >Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms

【24h】

Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms

机译：海藻酸抗酸剂（Gaviscon DA）咀嚼片可减少中国胃食管反流病和烧心症状患者的食管酸暴露

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVE: To assess the efficacy of Gaviscon Double Action (DA) alginate antacid chewable tablets for reducing esophageal acid exposure in Chinese patients with gastroesophageal reflux disease (GERD).

机译：目的：评估加维康双作用海藻酸抗酸剂咀嚼片在中国胃食管反流病（GERD）患者中减少食管酸暴露的疗效。

著录项

来源
《Journal of digestive diseases》 |2016年第11期|共10页
作者
Yuan Yao Zong; Fang Jing Yuan; Zou Duo Wu; Levinson Nigel; Jenner Bartosz; Wilkinson Joanne;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
esophageal pH monitoring; esophagitis; gastroesophageal reflux disease; heartburn; sodium alginate;

机译：食管pH监测;食管炎;胃食管反流病;烧心;海藻酸钠;

相似文献

外文文献
中文文献
专利

1. Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms [J] . Yuan Yao Zong, Fang Jing Yuan, Zou Duo Wu, Journal of digestive diseases . 2016,第11期

机译：海藻酸抗酸剂（Gaviscon DA）咀嚼片可减少中国胃食管反流病和烧心症状患者的食管酸暴露
2. Retraction: Randomised clinical trial: The clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China by J. Sun, C. Yang, H. Zhao, P. Zheng, J. Wilkinson, B. Ng, Y. Yuan. Aliment Pharmacol Ther Aliment Pharmacol Ther . 2015;42:845‐854. [J] . Alimentary pharmacology & therapeutics. . 2018,第9期

机译：撤回：随机临床试验：J. Sun，C. Yang，H.杨，H. 赵，P.郑，J.Wilkinson，B.NG，Y.元。与苜蓿药狼一起药。 2015; 42：845-854。
3. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China [J] . Sun J., Yang C., Zhao H., Alimentary pharmacology & therapeutics. . 2015,第7期

机译：随机临床试验：海藻酸钠-抗酸药（Gaviscon Double Action）与安慰剂相比，可减轻中国有症状胃食管反流病（GERD）的上消化道症状的临床疗效和安全性
4. A Multi-Parametric System for Gastroesophageal Reflux Disease Diagnosis in Newborn Patients [C] . A. Barriga-Rivera, M. J. Moya-Jimenez, M. Elena Perez, World Congress on Medical Physics and Biomedical Engineering . 2013

机译：新生儿患者胃食管反流疾病诊断的多参数系统
5. Prospective evaluation of serum vitamin B12 levels in patients receiving long-term lansoprazole for gastroesophageal reflux disease. [D] . Sotiriou, Christopher Gus. 2000

机译：长期接受兰索拉唑治疗胃食管反流病患者的血清维生素B12水平的前瞻性评估。
6. Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China [O] . J. Sun, C. Yang, H. Zhao, -1

机译：随机临床试验：海藻酸钠-抗酸药（Gaviscon Double Action）与安慰剂相比可减轻中国有症状胃食管反流病（GERD）的上消化道症状的临床疗效和安全性
7. Retraction: Randomised clinical trial: The clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China by J. Sun [O] . 2018

机译：撤回：随机临床试验：藻酸盐 - 抗酸（Gaviscon双作用）对安慰剂的临床疗效和安全性，用于通过J. Sun在中国的症状胃食管反流疾病（GERD）中的上胃肠道症状降低

Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms

摘要

著录项

相似文献

相关主题

期刊订阅